The Emory‐Sage‐SGC‐JAX TREAT‐AD Center: Developing Resources for Alzheimer’s Disease Novel Targets
All data, protocols, reagent sets, and chemical tools are made widely available on the AD Knowledge Portal with no intellectual property claims. Target Risk Scores and biodomains are accessible through Agora. For more information and the full target portfolio see www.treatad.org.
Authors
- Ranjita Betarbet (ORCID: https://orcid.org/0000-0002-4792-8952)
- Frank M. Longo (ORCID: https://orcid.org/0000-0002-9514-7325)
- Karina Leal
- Jesse C. Wiley (ORCID: https://orcid.org/0000-0002-1430-772X)
- Gregory A. Cary (ORCID: https://orcid.org/0000-0003-3573-5229)
- Elizabeth Zoeller (ORCID: https://orcid.org/0000-0001-9588-3114)
- Jessica E. Young
- Haian Fu
- Stacey J Sukoff Rizzo
- Yuhong Du
- Levon Halabelian
- Allan I. Levey
- Gregory W Carter
- Aled M Edwards
Institutions
- University of North Carolina at Chapel Hill (US)
- Sage Bionetworks (US)
- Emory University (US)
- University of Pittsburgh (US)
- University of Toronto (CA)
- Structural Genomics Consortium (CA)
- Jackson Laboratory (US)
- Stanford University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_103791
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00